Venetoclax | Annual Sales Report

2024 ACI Convention

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Abbvie

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 1,337

2019 Revenue in Millions : 792

Growth (%) : 69

Product Web Link

Corporate PDF

02 Brand Name : Venclexta

2024 ACI Convention

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 1,820

2020 Revenue in Millions : 1,337

Growth (%) : 36

Product Web Link

Corporate PDF

03 Brand Name : Venclexta

2024 ACI Convention

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 2,009

2021 Revenue in Millions : 1,820

Growth (%) : 10

Product Web Link

Corporate PDF

04 Brand Name : Venclexta

2024 ACI Convention

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 2,288

2022 Revenue in Millions : 2,009

Growth (%) : 14

Product Web Link

Corporate PDF

05 Brand Name : Venclexta

2024 ACI Convention

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Abbvie

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 344

2017 Revenue in Millions : 0

Growth (%) : NA

Product Web Link

Corporate PDF

06 Brand Name : Venclexta

2024 ACI Convention

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AbbVie